Literature DB >> 24477322

Quality of life in patients with craniocervical dystonia: Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)".

Margherita Fabbri1, Maria Superbo, Giovanni Defazio, Cesa Lorella Maria Scaglione, Elena Antelmi, Giacomo Basini, Stefania Nassetti, Fabio Pizza, Rosaria Plasmati, Rocco Liguori.   

Abstract

Dystonia is a disabling and disfiguring disorder that can often affect many aspects of patients' daily lives, and lower their self-esteem. To date, quality of life (QoL) has been assessed in dystonic patients using generic measures that do not address the specific problems of this diagnostic group. Recently, two disease-specific scales "The Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)" were validated for measuring QoL in craniocervical dystonia patients. No disease-specific scales for QoL for dystonic patients are currently available in Italian. The aim of our study was to produce and validate the Italian version of the CDIP-58 and CDQ-24. We obtained the Italian version of CDQ-24 and CDIP-58 with a back-translation design. Both scales were applied to a population of 94 craniocervical dystonia patients along with the Short Form 36 health-survey questionnaire (SF-36), both before and 4 weeks after botulinum toxin therapy. A group of 65 controls matched for sex, age and comorbidity underwent the SF-36. Internal consistency was satisfactory for all subscales. Both the CDIP-58 and CDQ-24 showed moderate to high correlations with similar items of the SF-36. Sensitivity to change was confirmed by highly significant improvements in all CDQ-24 subscales and by moderate improvements in three out of eight CDIP-58 subscales and total score. This is the first Italian study on QoL in dystonia patients. We validated the Italian version of two disease-specific questionnaires to evaluate QoL in craniocervical dystonia patients. These scales could be useful for both clinical practice and clinical trials.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24477322     DOI: 10.1007/s10072-014-1642-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  20 in total

1.  Impact of cervical dystonia on quality of life.

Authors:  Laura Camfield; Yoav Ben-Shlomo; Thomas T Warner
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

2.  An epidemiologic survey of dystonia within the entire population of northeast England over the past nine years.

Authors:  Anthony G Butler; Philip O Duffey; Maurice R Hawthorne; Michael P Barnes
Journal:  Adv Neurol       Date:  2004

3.  Prevalence of primary focal and segmental dystonia in Oslo.

Authors:  Khanh-Dung Le; Beate Nilsen; Espen Dietrichs
Journal:  Neurology       Date:  2003-11-11       Impact factor: 9.910

Review 4.  Generic and disease-specific measures in assessing health status and quality of life.

Authors:  D L Patrick; R A Deyo
Journal:  Med Care       Date:  1989-03       Impact factor: 2.983

5.  CDIP-58 can measure the impact of botulinum toxin treatment in cervical dystonia.

Authors:  S J Cano; J C Hobart; M Edwards; R Fitzpatrick; K Bhatia; A J Thompson; T T Warner
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

6.  The epidemiology of primary dystonia: current evidence and perspectives.

Authors:  G Defazio
Journal:  Eur J Neurol       Date:  2010-07       Impact factor: 6.089

7.  A prevalence study of primary dystonia in eight European countries.

Authors: 
Journal:  J Neurol       Date:  2000-10       Impact factor: 4.849

8.  Effect of dystonia and botulinum toxin treatment on health-related quality of life.

Authors:  C M Gudex; M R Hawthorne; A G Butler; P Duffey
Journal:  Mov Disord       Date:  1998-11       Impact factor: 10.338

9.  The impact of blepharospasm and cervical dystonia on health-related quality of life and depression.

Authors:  J Müller; G Kemmler; J Wissel; A Schneider; B Voller; J Grossmann; J Diez; N Homann; G K Wenning; P Schnider; W Poewe
Journal:  J Neurol       Date:  2002-07       Impact factor: 4.849

10.  Treatment of cervical dystonia: a comparison of measures for outcome assessment.

Authors:  R Lindeboom; J W Brans; M Aramideh; H D Speelman; R J De Haan
Journal:  Mov Disord       Date:  1998-07       Impact factor: 10.338

View more
  3 in total

1.  Development and validation of a clinical scale for rating the severity of blepharospasm.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Glenn T Stebbins; Angelo F Gigante; Gina Ferrazzano; Antonella Conte; Giovanni Fabbrini; Alfredo Berardelli
Journal:  Mov Disord       Date:  2015-04       Impact factor: 10.338

2.  Evaluation of anxiety and depression scales and quality of LIFE in cervical dystonia patients on botulinum toxin therapy and their relatives.

Authors:  Dursun Ceylan; Sevda Erer; Mehmet Zarifoğlu; Nevin Türkeş; Güven Özkaya
Journal:  Neurol Sci       Date:  2019-01-18       Impact factor: 3.307

Review 3.  SF-36 total score as a single measure of health-related quality of life: Scoping review.

Authors:  Liliane Lins; Fernando Martins Carvalho
Journal:  SAGE Open Med       Date:  2016-10-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.